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Abstract 
The occurrence of cardiovascular diseases increases with age independent of other risk factors, 
and the percentage of senescent cells is significantly elevated in vascular cells at atherosclerotic sites. 
Patients with accelerated aging syndromes caused by mutant lamin A protein, a structural component in 
nuclear lamina, also share many similarities with normal aged people, including the propensity to develop 
atherosclerosis. Recent studies have revealed the accumulation of prelamin A in normal aged vascular 
cells, and that lamin A participated as a mechanosensitive molecule in regulating various cellular events. 
These findings suggest that the ectopic expression of mutant lamin A or lamin A precursor (prelamin A) 
not only causes defects in cell mechanics, but it also disturbs stress-induced mechanotransduction 
pathways involving lamin A, both of which may contribute to vascular dysregulation. This review 
summarizes the current understanding of how lamin proteins are involved in vascular cell during aging, 
with a particular focus on the effect of mechanical stresses from blood flow on nuclear lamina of 
endothelial cells. Related studies are clarifying the role of lamin A in the progression of atherosclerosis, 
which will aid in the development of potential therapies for those suffering from lamin A-associated 
accelerated aging syndromes.    
Keywords: lamins, laminopathies, progerin, vascular aging, atherosclerosis 
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1. Introduction 
 Cardiovascular disease (CVD) is among the leading causes of death in the United States [3]. The 
progression of CVD often initiates on the endothelium, which generally acts as the first barrier to separate 
pulsatile blood flow and the interstitium, and at the same time provides semi-permeability for solutes and 
fluids to establish vascular homeostasis [4-6]. Many vascular risk factors, such as hypercholesterolemia, 
hypertension and aging were found to disturb endothelial functions by activating endothelium, and that 
activation will promote the recruitment and differentiation of circulating monocytes at the local area, 
which is followed by smooth muscle cells (SMC) proliferation due to altered cell-cell communications. 
These cellular events accompanied with the overproduction of extracellular matrix (ECM) together 
accelerate the atheromatous plaque buildup [7]. This disease progression is known as atherosclerosis, and 
the plaque rupture can cause severe thrombosis and even death in cases such as stroke or heart attack [8].    
 Vascular cells experience mechanical stimuli (tangential shear stress and circumferential strain) 
that are generated by the pulsatile blood flow in vivo, as shown in Figure 1 [9]. These mechanical cues 
also play an important role in the progression of atherosclerosis. Previous studies have shown that the 
atherosclerosis formation sites are structure-specific, preferentially occurring at arterial curvatures and 
branching points. At these sites vascular cells experience oscillatory and low shear stress and increased 
cyclic strain [10-13]. These mechanical forces have been shown to constantly regulate vascular 
physiology and pathology. In endothelial cells, the actin stress fibers aligned along the direction of 
minimum substrate deformation, for example the direction oblique to applied uniaxial stretch in vitro [14-
19], probably through the activation of RhoA by Rho-guanine nucleotide exchange factors (Rho-GEF) 
[20]. After exposure to regular shear stress, the filaments reoriented along the flow direction in 
concomitance with remodeling of cell-substrate adhesion and cell-cell adherent junctions [21]. The 
combination of these two physiological mechanical forces can also produce a synergistic effect on actin 
remodeling patterns [22]. Moreover, the angle between the flow and cell axis could have differential 
effects on the activation of endothelial nitric oxide synthase (eNOS) and NF-ĸB (a proinflammatory 
transcription factor). These findings suggest the capacity of hemodynamic forces on remodeling the 
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endothelial morphology in a force pattern dependent manner [23]. Selective gene expression and 
biochemical production in vascular cells can also be altered by distinct patterns of mechanical forces [24-
27]. Endothelial microRNAs (miRNAs) expression profile that is critical in regulating diverse cell events, 
including cell apoptosis and proliferation, was shown to depend on the shear stress pattern [28,29]. The 
production of endothelin-1, intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 
1 (VCAM-1), E-selectin and NOS activity were also sensitive to shear pattern [14-16,18,19,30-32]. It is 
recently reported that the endothelial sensitivity to the flow can be regulated by non-canonical Wnt 
signaling [33]. Also, endothelial cells from different species or vascular beds can elicit differential 
oxidative responses and gene expression profiles toward mechanical forces [34-36]: Sung et al. reported 
that human aortic endothelial cells (HAEC) were more susceptible to fluid agitation, while HUVECs were 
more sensitive to cyclic strain in terms of the productions of reactive oxygen species (ROS) and cell 
adhesion molecules. These findings suggest that distinct mechanotransduction responses may exist in 
cells from different vascular origins [37].   
  
 
 
 
 
 
 
 
 
The nucleus also plays a significant role in the mechanotransduction pathways by nucleo-
cytoskeletal coupling via Linker of Nucleoskeleton and Cytoskeleton (LINC) complex [38], a mechano-
responsive protein complex associated within nuclear envelope, which contains SUN-domain proteins 
(SUN1 and 2) and KASH-domain proteins (Nesprin 1, 2, and 3) that bind to nuclear lamina and 
Blood flow 
Velocity profile 
Shear Stress Pressure 
Pressure Shear Stress 
Figure 1. Illustrative image of main hemodynamic forces exerted on vascular wall. The viscous characteristic of 
blood flow induces non-uniform velocity profile within the blood vessel, which leads to the creation of shear 
stress parallel to the blood flow direction. The pulsatile blood flow also induces pressure changes onto the vessel 
wall [2], which on the other hand causes blood vessels to stretch circumferentially. Arrows denote the directions 
of blood flow and mechanical forces. Shear stress is tangential to vessel wall, while pressure is perpendicular.  
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cytoskeleton, respectively [39]. Endogenous and exogenous forces as mechanical stimuli can trigger 
structural and compositional changes in nuclear envelope, and modulate gene expression and cell 
behaviors by activating many downstream regulators [40-42].  
The integrity of nucleus is largely supported by nuclear lamina, a dynamic network that sits 
underneath the inner nuclear membrane composed of lamin polymers and lamin-associated proteins [43]. 
As the main contributor to nuclear mechanical properties, the lamina is crucial in preventing DNA 
damage during nuclear deformation and cell migration [44,45], and its proximity to heterochromatin also 
enables its role in stabilizing spatial organization of genome [46]. It helps transfer forces to the tethered 
chromatin via coupling with LINC complex, and responds to changes in the ECM by mediating lamins 
expression, in a manner that helps maintain nuclear stiffness in various tissues [47,48]. The nuclear 
lamina is involved in various cellular events that determine cell fate, and defects in the lamina contribute 
to disease phenotypes and impaired mechanotransduction pathways.    
Lamins are type V intermediate filament (IF) proteins recognized as a filamentous network at first 
glance [49]. Besides acting as a structural support for nuclei under mechanical stresses, lamins were also 
found to participate in DNA replication and repair, as well as in gene regulations through interactions 
with peripheral heterochromatins or mechanosensitive transcription factors (TFs) [50-53]. Recent findings 
have indicated correlations between mutated lamin forms and atherosclerosis during aging process, 
suggesting that lamin proteins may play a role in the development of atherosclerosis particularly during 
normal aging [54-56].    
The lamins are classified into two subgroups in vertebrates: A-type lamins (encoded by LMNA 
gene) and B-type lamins (encoded by LMNB1 or LMNB2 gene) by different isoelectric values [57,58]. 
They both have the protein structures and domain interactions typical of intermediate filaments, and 
further associations of these lamin polymers eventually generate filaments with 10 nm in diameter in vitro 
[59-61]. Although evidence showed that A- and B-type lamins form distinct but interacting network in 
mammalian cells [62], the in vivo organization of lamins filaments remains unknown, and it is considered 
to be more heterogeneous than the observed woven-like network in Xenopus laevis oocyte, which only 
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has B-type lamins [61]. Recent application of cryo-electron tomography (cryo-ET) on the lamina revealed 
its supramolecular organization: a 3.5 nm thick lamin filament meshwork with globular structures that 
represent the immunoglobulin-fold domains [63].   
Within the lamin family, lamin A and lamin C are two major forms originated from LMNA gene 
by alternative splicing, and lamin B1 and lamin B2 are generated from LMNB1 and LMNB2, respectively 
[64]. All major lamins except lamin C possess a CAAX motif at the carboxyl-terminus after protein 
synthesis where the cysteine (C) is farnesylated by farnesyltransferase (FT) to facilitate the protein 
localization at the nuclear envelope (NE). After that, the aaX residues are hydrolyzed by farnesylated 
proteins-converting enzyme 2 (FACE2) on lamin B1 and B2, or by a zinc metallo-endoprotease 
(Zmpste24 or FACE-1) on prelamin A (the precursor for lamin A). The farnesylated cysteine at the end 
will be methylated afterwards, and all those steps will lead to the permanently farnesylated tails on B-type 
lamins. However, the additional removal of the last 15 amino acids (including the farnesylated cysteine) 
by Zmpste24 will occur on lamin A precursor before it proceeds to mature lamin A (Figure 2) [65].  
Aside from the slight differences in post-translational steps, A- and B-type lamins were also 
found to perform differently in multiple cellular events. During mitosis, the nuclear lamina undergo 
disassembly, where A-type lamins diffused into the nucleoplasm at early prophase, while B-type lamins 
tended to be fragmented and concentrated near the mitotic spindle later during metaphase [66]. The 
reassembly timing for them also differed, indicating their diverse disassembly and reassembly 
mechanisms during cell division [67]. Furthermore, contributions of these lamins to nucleus mechanics 
are also distinct. While the ablation of lamin A/C or lamin A resulted in a compromised nuclear shape and 
stiffness in fibroblasts, lamin B1-deficient cells had more nuclear blebs (membrane invaginations and 
protrusions) without discernible alternations in nuclear mechanics [68]. This discrepancy may be due to 
greater association and stabilization between A-type lamins and nuclear structural proteins, such as 
emerin, nesprins, and lamina-associated polypeptide 2 isoform alpha (LAP2α) [69-71].   
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In the past decades, more than 17 diseases have been reported to be associated with lamin gene 
mutations (mainly LMNA gene), and they are collectively named laminopathies [50]. Mutations 
involving LMNB1 and LMNB2 genes mostly cause disorders in neural development and degeneration, 
such as adult-onset autosomal dominant leukodystrophy (ADLD) and are often lethal [72-74]. The 
essential role that B-type lamins play in cell viability might explain the limited quantity of identified 
mutations in LMNB genes [75]. Conversely, over 500 missense LMNA mutations have been recognized 
that mainly affected the progeny of mesenchymal stem cells [76,77]. Patients with LMNA mutations 
often experienced multiple phenotypes, including defects in skeletal and cardiac muscles and loss of 
subcutaneous adipose tissue, such as in Emery-Dreifuss muscular dystrophy (EDMD) and Dunnigan-type 
familial partial lipodystrophy (FPLD) [78], as well as peripheral nerve dysfunctions, or disorders 
resembling aging syndromes in young patients (Hutchinson-Gilford progeria syndrome (HGPS)) [79].  
Figure 2. Schematic drawing of typical lamins structures (A), including a highly conserved α-helix rod domain and 
a more divergent N-terminal head and a C-terminal tail that contains NLS (nuclear localization signal that contains 
chromatin binding site) and Ig fold domain [1]. (B) Post-translational modifications in lamin proteins. Lamins after 
protein synthesis contain a complete –CAAX motif at C-terminus (a), and the cysteine in –CAAX motif is 
farnesylated by farnesyltransferase (b). The aaX residues are removed and the cysteine at the C-terminus is 
methylated (c). Mature lamin A will be generated after the last 15 amino acids being removed by ZMPSTE24 (a 
zinc metallo-endoprotease) (d).  
α-helical rod domain NLS 
N-terminal 
Ig fold 
CAAX 
C-terminal 
S 
CAAX 
COOH 
COOH 
S 
C COCH 
3 
Cysteine farnesylation 
Hydrolysis of -aaX and 
carboxy methylation 
Mature lamin A 
Last 15-amino-acid 
deletion at C-terminus 
(a) 
(b) 
(c) 
(d) 
A 
B 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
6 
 
Notably, the systematic premature aging syndromes (also known as progeroid syndromes) by 
missense mutations in LMNA, such as Atypical Werner syndrome (WS), Restrictive dermopathy (RD) 
and HGPS (also called Progeria) have attracted enormous attention given their correlations with the 
normal aging process. Multiple and overlapping phenotypes were identified in those diseases, including 
postnatal growth retardation, wrinkled skin, substantial hair loss [80]. While sequencing technique 
suggested genetic heterogeneity for MAD (Mandibuloacral Dysplasia) and Atypical WS [81], cells from 
HGPS patients were generally reported to have missense mutations in exon 11 on the LMNA gene. This 
creates a cryptic splice site responsible for the deletion of 50 amino acids near C-terminus on prelamin A, 
resulting in an absence of the recognition site for Zmpste24 to remove the final 15-amino-acid at C-
terminus. This lack of post-translational modification leads to the generation of a truncated prelamin A 
called progerin that has a permanently farnesylated tail. RD was reported to have an extra removal of 40 
amino acids (totally 90) on prelamin A, which was believed to cause more severe outcomes than HGPS 
given its lethality in newborns [82,83]. Interestingly, similar phenotypes were also observed in patients or 
mouse models with mutations or deficiency in Zmpste24 gene [84].   
Except for the resemblance in appearance between patients with progeroid syndromes (mainly 
HGPS) and elderly people, they also shared some similarities at the cellular level, including increased 
DNA damage, defects in DNA repair and shortened telomere length that significantly impaired cell 
proliferation capacity [85]. The accumulated DNA damage, as one of the hallmarks of normal aging, was 
often found in senescent cells [86,87]. Like elderly people, patients with progeriod syndrome were also 
prone to developing advanced atherosclerotic lesions, but the extensive loss of SMC in arteries and 
thickened adventitial fibrosis in veins were only observed in HGPS patients [88], and patients with 
laminopathies of premature aging did not exhibit all normal aging phenotypes [89]. However, the 
presence of  truncated prelamin A in normal aged individuals (at a much lower level) as well as their high 
genomic instability, telomere attrition, epigenetic and metabolic alternations and cell senescence, 
particularly in cardiovascular system, still suggest lamin’s role in promoting vascular aging [86,90-93]. 
While B-type lamins, especially lamin B1 were greatly lost in senescent cells [94], their deficiencies were 
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recorded to mostly affect nervous system and brain function [72]. However, little evidence has been 
shown on the role of lamin B with vascular aging or nuclear mechanics [68], and the relationship between 
B-type lamins and cell senescence remain to be recognized. Related studies might shed more light on the 
discoveries on aging mechanisms and potential treatments for those patients suffered from accelerated 
aging diseases [95,96].  
2. Roles of lamin A/C in maintaining cell functionality 
Lamin A/C serves not only as structural components to support nuclear mechanics, but also 
interacts with many transcription factors and periphery heterochromatin to regulate gene expression 
[97,98]. Lamin A/C-associated disorders that affect the vascular system suggest that lamin A/C plays an 
important role in supporting cell mechanics and in signaling processes under mechanical forces, which 
may help to understand the underlying mechanisms of atherosclerotic lesion formation process 
[77,88,99,100].   
2.1 Mechanical roles of Lamin A/C 
 After incorporating into nuclear lamina, lamin A/C forms a filamentous meshwork that modulates 
the dynamic mechanical properties of nucleus in accordance with the internal and external forces of the 
cell. This process is achieved not only by the physical connections among ECM, focal adhesions, 
cytoskeleton and nuclear envelope, but also by many mechanosensitive molecules that were recognized as 
transducing mechanosignals into nucleus to elicit changes in gene expression profiles [101]. For instance, 
ECM stiffness was found to be parallel to lamin A/C expression. The resulting post-translational 
modifications in lamin A/C degradation and phosphorylation via coupling with myosin-IIA can lead to 
changes in the Serum Response Factor (SRF) pathway, which in turn regulates actomyosin expression 
[102]. This self-regulating mechanism involving lamin A/C allows cells to respond to its environmental 
stresses through changes in cell and nuclear mechanics. Since vascular cells exist in a mechanically active 
microenvironment, it was proposed that lamin A/C is essential in modifying these cells behaviors in 
response to mechanical forces, and that may partially explain why the absence or mutations in lamin A/C 
can induce the most abnormalities in cells that are under mechanical loadings [97].   
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2.1.1 Lamin A/C Effects on Nuclear Mechanics 
Nuclear lamina was proposed to be a natively compressed and elastic network in static state, 
which can resist potential overloading force to prevent nuclear breakdown [103]. Different types of lamin 
might contribute to distinct mechanical properties of the nucleus. Observations from micropipette 
aspiration experiment revealed that B-type lamins contributed more to the nuclear elasticity, while A-type 
lamins acted to resist nuclear deformation as a viscous network [104,105].  
While studies showed that lamin A/C is homogeneously distributed at the nuclear periphery 
which delineates the nuclear shape, human dermal fibroblasts with silenced or mutated lamin A/C had 
significant nuclear defects in morphology, such as distorted nuclear periphery and nuclear blebs or 
invaginations [106]. Increased nuclear deformation was also observed in fibroblasts without lamin A/C 
present or with lamin mutations that can cause muscular defects. However, fibroblasts from FPLD 
patients showed normal nuclear stiffness [107]. And in HGPS skin fibroblasts that overexpressed 
progerin, the stiffness was reported to increase, as well as elevated mechanosensitivity [108]. Those 
findings are consistent with the varied laminopathy phenotypes by different de novo mutations of lamin 
A/C, indicating that distinct changes in nuclear mechanics can be induced by dissimilar amino acid 
substitutions on lamin A/C sequence, which could differentially affect the domains or higher order 
structures on lamin A/C, as well as their filamentous network within the lamina [107,109]. 
Specifically, the increased nuclear stiffness in HGPS cells might be related to the pathological 
mechanism of progerin, which tended to aggregate at the nuclear periphery and hamper the deformation 
of nuclei toward mechanical forces [108,110]. The birefringent orientation of lamins found in HGPS cells 
may also contribute to the stiffened nuclei [111]. Other than the observed mechanical abnormalities in 
fibroblasts, the introduction of Δ50 lamin A in HeLa cells also disturbed their morphological responses to 
laminar shear stress. Similar nuclear defects were also reported in lamin A/C-deficient multinucleated 
myotubes, indicating the broad effects of lamin A/C on nuclear mechanics regardless of cell types 
[68,112]. While the treatment of farnesyltransferase inhibitors (FTI) has successfully rescued nuclear 
shape and the stiffness of HGPS fibroblasts, by removing the farnesylated tail, the cellular 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
9 
 
mechanosensitivity was not ameliorated [108]. Therefore, the recovery of stiffness by releasing progerin 
into nucleoplasm is not sufficient to help cells to resist external forces. 
2.1.2 Lamin A/C Effects on Whole Cell Mechanics  
Nuclear lamina has been shown to be associated with cytoplasmic actin filaments, microtubules 
and intermediate filaments through emerin and LINC complex [46]. Given the fact that the nucleus and 
cytoplasm are interlinked by physical connections [113], it is not surprising to observe the changes in 
whole cell mechanical properties when lamin A/C was defective. 
The deficiency of lamin A/C in mouse embryonic fibroblasts (MEFs) can lead to softened 
cytoplasm, compromised viscoelastic properties of the cytoskeleton, decreased cell polarization and 
migration rate [114,115]. Similar defects were observed in fibroblasts with mutant LMNA (LmnaL530P/ 
L530P) that yield HGPS phenotypes in human [116]. These phenomena suggest that the dysfunctional lamin 
A/C can have adverse effects on cell mechanics. More specifically, silencing lamin A/C can greatly 
change cytoskeletal structures in MEFs and 3T3 cells, such as disturbed emerin and nesprin-3 
localization, depolymerization of actin filaments at perinuclear regions, and abnormal absence or 
aggregation of vimentin [115]. However, in a mouse model with only lamin C expressed, the targeting of 
emerin to NE was reported to be normal [117]. This discrepancy might suggest the assistant role of lamin 
C in helping emerin at nuclear membrane. Mutations in LMNA responsible for muscular dystrophies 
were found to cause defective actin-dependent nuclear movement, while microtubule-mediated 
centrosome positioning was not interfered. On the other hand, in LMNA-/- fibroblasts or those with 
LMNA mutations that cause HGPS or affect adipose tissues, emerin was mislocalized and  related to that, 
disturbed microtubule-dependent cell polarization was observed [115,118]. These findings suggest 
distinct pathologies of laminopathies with different phenotypes [118].   
Overall, evidence has shown that both nuclear and whole cell mechanics were weakened by 
mutated or deficient lamin A/C with dysfunctions in various structural proteins, suggesting structure-
dependent complexity in lamin A/C functions. These findings also highlight the necessity to distinguish 
and separate the effects brought by different mutated isoforms of lamin A/C. Moreover, the observation 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
10 
 
that releasing progerin from nuclear periphery did not completely recover cellular mechanosensitivity 
suggests that there might be additional pathogenic mechanisms for mutated lamin A with the farnesylated 
tail, besides its ability to disturb cell mechanics by permanently attaching to the lamina network.   
2.1.3 Lamin A/C Effects on Vasculature System and Endothelial Cells 
Although lamin A and lamin C are broadly present in many differentiated tissues, their expression 
levels were reported to scale with tissue elasticity that is largely determined by the surrounding ECM. In 
other words, stiffer tissue elicited more lamin A/C expression, while softer tissue had B-type lamins 
dominant [105]. Moreover, exclusive lamin C expression was observed in mouse central nervous system 
(cerebellum and cortex) except in capillary endothelial cells and the meninges. This is proposed to be 
linked to miR-9, a brain specific microRNA that was bound to prelamin A and downregulated its 
expression [105,119]. Therefore, it is critical to be aware of the distinct expression patterns and functions 
that lamin A/C might have in tissues possessing different stiffness. Arterial stiffness, on another hand, is 
associated with other factors, including endothelial signaling and VSMCs (vascular smooth muscle cells) 
tone that were also found to be modified by lamin A/C [120-122]. Given the associated mechanical 
defects due to the genetically mutated lamin A, it is worthwhile to analyze how lamin A/C modifies 
vascular cells in cell mechanics.   
Many articles have addressed the vascular specific disorders brought by abnormal lamin A/C. 
LMNA knockout mice that exhibited dilated cardiomyopathy (DCM) had altered nuclear shape and 
disrupted connections between the nucleus and desmin (muscle-specific IF) in cardiomyocytes and 
skeletal muscle cells [123-125]. Several missense mutations identified in patients with DCM were also 
found to affect cardiac conduction system or heart muscle [126]. Reduced lamin A/C expression that was 
induced by hypertension promoted the hyperproliferation of VSMCs, indicating the ability of lamin A/C 
in preventing stretch-induced VSMC proliferation. The suppressions of lamin A/C and nesprin 
expressions by low shear stress in primary rat aortic ECs also indicate the potential dysregulations of 
lamin A/C-related nucleo-cytoskeletal connections induced by abnormal mechanical stress in ECs [127]. 
These data suggest the mechanosensitive role of lamin A in vascular system. Further studies are needed to 
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better understand the role of abnormal nuclear lamina in morphological remodeling processes of 
endothelial cells under flow.  
2.2 Signaling Roles of A-type Lamins 
Besides acting as a structural support to prevent the nucleus from breakdown, lamin A/C also 
binds to various transcription factors and chromatins. They are present both at the nuclear periphery and 
throughout the nucleoplasm to form relatively stable structures in a dynamic equilibrium state, and 
interact with other nuclear molecules to mediate cell functions [128]. 
2.2.1 Molecular Interactions of Lamin A/C  
A-type lamins associate with chromatins at lamina-associated domains (LADs) that repress gene 
expression in most cases, and they also interact with many transcription factors to regulate cell 
differentiation and proliferation [129-134]. Qi, et al. classified the primary functions of DNA segments 
that were bound to lamin A/C in VSMCs, and more than 35% of the DNA was of the phosphoprotein 
category [135], indicating the role of lamin A/C in post-translational modifications and signaling 
molecules regulations. Abnormal fragmentation of heterochromatin, changes in epigenetic marks and 
mislocalizations of transcription factors were also reported in cells with deficient or mutated LMNA gene, 
suggesting their critical roles in maintaining cell functionality through epigenetic regulations [136-139].  
Multiple mechanisms are believed to contribute to these lamin A/C-associated gene regulations 
such as: providing the interaction platform for signaling molecules, hampering the import of transcription 
factor units to inhibit signal transduction, as well as regulating tissue-specific pathways by organizing 
periphery heterochromatin [140]. For example, megakaryoblastic leukaemia 1(MKL1), a transcription 
factor that regulates cell differentiation, migration and proliferation, failed to localize to nucleus in 
LMNA-/- and LMNA N195K mutant MEFs due to defective actin dynamics and loss of emerin expression 
[141]. Impaired Wnt signaling and reduced nuclear localization of lymphoid enhancer binding factor 
(LEF1) in a HGPS mouse model were observed to affect ECM synthesis [142]. Moreover, the critical 
position of lamin A/C in nucleo-cytoskeletal coupling complex also facilitates their involvement in 
mechanotransduction pathways, for instance, the attenuated activation of NF-κB signaling by biaxial 
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cyclic strain in LMNA-/- MEFs [143,144]. This finding suggests that mutation in or lack of lamin A/C can 
prompt not only changes in mechanical properties, but also in mechanotransduction pathways induced by 
external stimuli.   
2.2.2 Lamin A/C in Mechanosignaling Pathways Associated with Atherosclerosis 
Lamin A/C has been shown to participate in many mechanotransduction pathways in vascular 
cells, and their mutations can led to vascular dysfunctions in DNA repair and inflammatory responses 
[145,146]. Studies have revealed their pivotal roles in many mechanosignaling pathways to maintain 
vascular homeostasis, and changes in applied mechanical forces can interfere with lamin A/C-associated 
regulations in vascular cells. For instance, A-type lamins and emerin were reported to suppress VSMC 
proliferation in vitro under normal cyclic strain (5%), which was correlated with their associations with 
sequence-specific regions that enrich transcriptional factor motifs E2F1, E2F3, SP1 and Stat 1 [135]. 
Bovine aorta endothelial cells (BAEC) had defective shear stress-induced transcriptional activation of 
glucocorticoid response element (GRE) after silencing lamin A/C [147]. Low shear stress applied on 
primary aortic ECs resulted in increased proliferation and apoptosis in ECs, and the changes were shown 
to be induced by reduced lamin A/C expression and repressed activation of several TFs (Stat-1, Stat-3, 
Stat-5 and Stat-6) [127]. Those findings indicate the atheroprotective roles of lamin A/C in suppressing 
the stretch-induced VSMCs proliferation that can promote atherosclerotic lesion formation, as well as in 
participating shear stress-induced atheroprotective gene regulations in vascular ECs [11,148]. Moreover, 
the differential effects of lamin A expression on ECs and VSMCs in terms of low shear stress-induced 
secretary molecules PDGF-BB and TGF-β productions also indicate the existence of cell type-specific 
response of A-type lamins in vascular system [149].  
There are mainly two types of laminopathies involving atherosclerosis progression, FPLD2 and 
HGPS. Patients with FPLD2 that carry LMNA mutation at 482 codon often developed coronary heart 
disease in their adulthood, especially in women [150,151]. It was believed that metabolic disorders like 
insulin resistance contribute most to the premature atherosclerosis [152,153], but a recent study revealed 
that the R482W LMNA mutation responsible for FPLD2 led to the cascade of endothelial dysfunctional 
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events, including reduced NOS expression, activated proinflammatory molecules such as IL-6 and IL-8, 
and increased adhesion affinity with immune cells [154]. Similarly, the proinflammatory responses were 
also reported to be effected in HGPS ECs [7]. Combined with previous discussions of how hemodynamic 
forces regulate those endothelial functions in pathogenesis of atherosclerosis, it is suggested that the 
mutated lamin A/C isoforms can potentially disturb the atheroprotective pathways, and promote the 
expressions of atheroprone genes in endothelial cells at arterial sites that are exposed to irregular 
mechanical stresses. 
3. Correlations Between Lamin A/C and Cellular Aging 
 Lamin A/C expression seems to be regulated throughout development. For instance, evidence 
showed that lamin A/C did not appear until embryonic cell differentiation and the downregulation of 
several pluripotency genes like Tra-1-60 and SSEA-4 [155]. Their expression levels also varied in 
differentiated human tissues with differences in tissue stiffness [105,156]. Changes of lamin A/C over 
time can lead to many epigenetic changes, such as the induction of aberrant pathways that promote tumor 
cell migration and invasion in several types of cancers as well as in the aging process, which will be 
addressed in the following section [157]. 
3.1 Lamin A/C in Aging Process and Progeriod Syndromes 
Aging refers to the natural process that an organism undergoes over time, which comes with 
declinations in body functions and increasing probability of developing diseases and death. Many 
mechanisms of aging have been proposed recently, including genomic instability, telomere attrition, 
epigenetic alternations, loss of proteostasis, deregulated nutrient sensing, mitochondrial 
dysfunction,cellular senescence, stem cell exhaustion, and altered intercellular communication [86,158]. 
Cell senescence is a state of arrested cells growth with altered gene expression profile. It is triggered 
either by telomere shortening (replicative senescence) or other damage signals before cells reach their 
limited lifespan (premature senescence) [159,160]. Recent studies in the structural and functional 
alternations of lamin A/C in aging-related diseases revealed the similarities between the underlying 
mechanisms of laminopathies with that of aging pathologies, especially in nuclear architecture changes, 
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chromatin and epigenetic modifications and activation of senescence pathways [161-163]. Some aging 
phenotypes such as cellular senescence and telomere dysfunction were induced by several laminopathies 
or diseases with abnormal Zmpste24 expression [164-167]. These abnormalities have motivated the 
research on how lamin A/C-related dysfunctions contribute to the normal aging process.   
Many studies have addressed the role of progerin, the aberrant prelamin A isoform that causes 
HGPS, in contributing to accelerated aging. The expression of exogeneous progerin in normal fibroblast 
can induce replicative senescence and loss of telomeres, suggesting conserved progerin-dependent 
senescence pathways in normal cells [166]. In HGPS fibroblasts, progerin also accumulated in culture, 
accompanied with deteriorated nuclear shape and disorganized methylation pattern of histone 3 on lysine 
9 (H3K9) that overlapped with the phenotypes found in aged cells [168]. Positive detection of Δ150 
LMNA mRNA that was responsible for progerin synthesis was reported in normal fibroblasts, and the use 
of cryptic splicing site increased as the passage went up regardless of donors’ age [169]. Meanwhile, the 
localization of wild type lamin A/C was also altered in cells from old donors, where they were more 
accumulated at the nuclear envelope instead of present at both nuclear periphery and nucleoplasm as in 
young donor cells. Removal of progerin in cells from old individuals by the inhibition of the cryptic 
splicing site has rescued the nuclear defects in terms of the expression patterns of nuclear protein (HP1) 
and histone modifications (Tri-Me-K9H3) [170]. It is not yet known how progerin takes effects in normal 
aged cells at a very low expression level that did not change significantly over age (although the 
increasing trend was observed over in vitro culture) [171]. On the other hand, the downregulation of 
Zmpste24 gene due to increased sensitivity to oxidative stress during aging might be another cause for the 
prelamin A accumulation in aged cells [172]. Lack of Zmpste24 will interfere the prelamin A 
posttranslational modifications, and lamin A isoforms that possess the permanently farnesylated tail will 
be generated instead of the mature form [173,174].    
3.2 Molecular Mechanisms of Lamin A/C-dependent Premature Aging 
Multiple but not mutually exclusive mechanisms were proposed about how lamin A/C 
participates in cell senescence. Some studies hypothesized that progerin production in HGPS cells was 
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mediated by SRSF1 (serine-arginine rich splicing factor 1) and SRSF6, whose expressions were also age-
dependent [175,176]. Gene therapy to block the aberrant splicing site reversed the nuclear defects, and 
treated HGPS mice had elongated life span [177]. Another treatment by FTIs that inhibit prelaimin A 
farnesylation had rescued nuclear shape, and improved bone structure and vascular stiffness in both 
mouse models and patients with HGPS, as well as prevented SMC loss in mice model [178-183]. 
However, this treatment did not ameliorate DNA damage or reactivate checkpoint signaling pathways in 
HGPS and RD human fibroblasts. Other remnant problems of this treatment like the universal effects of 
FTI on farnesylation inhibition, and the retention of prelamin A at nucleoplasm still remain to be solved 
[184].  
Another hypothesis is that, the prelamin A-associated cell aging is caused by telomere shortening 
that can lead to alternative splicing events in multiple genes including LMNA [171]. Aberrations in 
chromosomes and telomeres were observed after inducing progerin into normal human dermal fibroblasts 
[167]. The introduction of exogenous telomerase into HGPS fibroblasts can significantly enhance cell 
propagation ability and prevent senescence with unchanged progerin level over passages, probably by 
interacting with telomeres and repressing p53 and Rb tumor-repressor pathways [171]. The production of 
progerin was only seen in cells with short telomeres, but was not observed in telomore-independent 
premature senescence induced by sodium butyrate or a histone deacetylase inhibitor [171]. These findings 
suggest that progerin-induced senescence was specifically driven by telomere shortening. However, this 
hypothesis remains to be challenged as limited signals were tested in this study.  
Besides telomere shortening, the extensive damage in DNA repair system and the changes in 
lamin A-associated regulating pathways were also reported to be potential mechanisms of cellular aging. 
Increased DNA damage, as well as the failure to respond to DNA damage and the hyperactivation of p53 
tumor suppressor pathway, were observed in Zmpste24 -/- fibroblast, indicating dysregulated DNA repair 
in response to accumulated farnesylated prelamin A [163,185]. As a result of DNA damage in Zmpste24 
deficient mice, NF-κB inflammatory signaling pathway was activated by a protein kinase ATM (staxia-
telangiectasia mutated) and its downstream factor NF-κB essential modulator (NEMO). This pathway was 
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involved in some progeroid phenotypes in those mice, since blocking the pathway greatly improved their 
biological characteristics [186-188]. However, the intact DNA repair pathways observed in a progeria 
mouse model with lamin A exon 9 deleted may indicate the trivial role of exon 9 region in maintaining 
genome stability [189]. Changes in epigenetic marks such as H3K27me3 and their causative 
heterochromatin reorganizations in human HGPS fibroblasts occurred prior to aberrations in nuclear 
shape [190]. Together with changes in histone methylation in HGPS and aging cells, these data suggest 
that general mechanisms of epigenetic control were shared by normal aging process and prelamin A-
induced premature aging diseases[91]. A more recent study showed that signaling pathway driven by a 
sequestered transcription factor NRF2 (nuclear factor (erythroid-derived)-like 2) was impaired in HGPS 
fibroblasts. It is a substrate for CAND1 gene with the capacity to prevent HGPS defects in vitro. NRF2 
expression was closely associated with progerin expression, antioxidant gene activation, and cell survival 
[191]. Although reactivation of NRF2 pathway did not completely restore all progerin-induced defects, 
this finding disclosed one of the molecular mechanisms in progerin-induced cellular defects, and provided 
new insight into lamin-A associated aging process. 
Furthermore, recent advances in stem cell research also indicate that regenerative dysfunctions 
may also contribute to premature aging [192,193]. The multiple roles that Notch signaling plays in 
vascular system may also be the link between progerin and vascular dysregulations. Notch signaling 
pathway was activated by ectopic progerin expression in human mesenchymal stem cells (hMSCs) [194]. 
The capacity of hMSCs to differentiate into adipocytes was largely compromised, which is consistent 
with the subcutaneous adipose tissue loss in HGPS patients [195].  
Overall, efforts have been invested to explore the underlying mechanisms of prelamin A induced-
senescence. Confirmations of the role of prelamin A in in vivo aging and comparison of molecular 
mechanisms in normal and premature aging laminopathies are needed to further understand how 
immature lamin A contributes to the aging process.  
3.3 Lamin A/C in Vascular Aging  
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As healthy individuals age, the risk of developing cardiovascular disease increases with age as a 
result of changes in in structure and functions of the vasculature [196-198]. Age-associated changes in 
vascular cells and ECM composition, such as elevated secretion of proinflammatory factors, increased 
invasive and migratory potentials, reduced production of vasodilators, as well as the changes in collagen 
and elastin components can lead to altered mechanical properties of vessel wall and inflammation 
[199,200]. For example, the stiffness and adhesion capacity of VSMCs were increased with aging [201], 
and the expression pattern of Sirt1, a deacetylase involving in multiple cellular events including anti-
inflammatory pathways in endothelial cells [202], was observed to be repressed in vascular aging [203]. 
Similar phenotypes were reported in prelamin A-induced progeroid syndromes, including characteristics 
of stiffened and calcified vessel wall, and activation of ICAM-1 and monocytes adhesion in ECs [204-
206]. Nevertheless, different phenotypes also existed between HGPS and aging individuals that were 
summarized by Brassard and colleagues [199], such as extensive atherosclerotic lesions, increased platelet 
count, prolonged prothrombin times, as well as the preserved flow-mediated dilation response in HGPS 
vessels, indicating dose-dependent effects of progerin in vascular system [207]. However, considering the 
similar vascular defects induced by prelamin A and physiological aging, the prelamin A-associated 
changes in vasculature may still be indicative of vascular aging. 
Evidence of restrictive detection of progerin in vascular cells from a HGPS patient indicates the 
preference of progerin accumulation in vascular system [100], and the activations of inflammatory 
responses and cell senescence in vascular ECs from FPLD2 patients also suggest the onset of 
atherosclerosis [154]. Immunostaining in a progeria mouse model revealed a significant loss of SMCs in 
large arteries accompanied with replacement of proteoglycan (PG) and collagen, and it was followed by 
adventitial thickening and arterial wall calcification that were the main contributors to vascular stiffening 
[204,208]. Several progeria mouse models were created to study the mechanisms underlying prelamin A-
induced premature aging, but not all HGPS syndromes were recapitulated by these models [90], for 
instance, the observation of intimal thickening in HGPS patients was not reported in the mouse model 
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[208], indicating the differences in progeria models across species, and the necessity of confirming the 
pathological findings in humans.   
Similarly, prelamin A accumulation in normal aging vascular cells can also impair their functions 
and disturb the vascular remodeling process. The detection of endogenous prelamin A was reported in 
VSMCs either from aged individuals or by serial culture in vitro, and it was accompanied with the 
increased sensitivity towards differentiation prior to compromised proliferation capacity, suggesting that 
prelamin A accumulation precedes the onset of senescence [55]. Although this attenuation was believed 
to be initiated by the downregulation of Zmpste24 along with cellular senescence [209], their expressions 
were heterogeneous in advanced atherosclerotic lesions, indicating additional regulatory factors 
responsible for prelamin A accumulation [55]. ECs and endothelial progenitor cells with inhibited 
Zmpste24 activity overexpressed farnesylated prelamin A, and the inflammatory factor ICAM-1 was 
activated (but not VCAM-1 and E-selectin), and the adhesion of monocyte was enhanced in ECs. The 
regenerative capacity in endothelial progenitor cells was also impaired in terms of microvascular network 
generation, which indicates the exhaustion of endothelial stem cell pool [206], together with the 
observation of reduced migration potential in melanoma cells overexpressing ∆50 lamin A explain the 
low incident rate of cancer in progeria patients, since neovascularization is critical for cancer 
development and progression [210,211].   
Besides the potential mechanisms discussed in the last section, altered cellular responses toward 
mechanical stresses were also closely linked to prelamin A-associated vascular disorders [199]. 
Cytoskeletal reorganizations, such as the reduced expressions of cytoskeletal proteins in SMCs under 
high shear stress in a progeria mouse model, were potentially responsible for the SMC loss in the medial 
layer of aorta during vasculopathy development [212]. Alternations in the mechanical properties of the 
vessel wall by prelamin A, such as vascular stiffening, were also critical in promoting vascular diseases 
[213]. One of the causes - ECM composition changes and the resulting proliferation arrest were observed 
in lamin A mutated fibroblasts, which is led by impaired Wnt signaling [142].  
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Overall, abnormalities in lamin A/C have been suggested to cause premature aging phenotypes 
and influence vascular system functions. The observations of prelamin A accumulation in normal aged 
cells also indicate the pivotal roles it could play in promoting the aging process and vascular diseases. 
Further validations of how prelamin A participates in cellular senescence and vascular aging, as well as 
their associated pathways are needed to assist in developing therapeutic mechanisms for prelamin A-
induced premature aging diseases. 
4. Conclusion  
Previous studies have demonstrated that, the development of atherosclerosis was closely related 
to the hemodynamic forces that stimulate various responses in vascular cells. On the other hand, the 
abnormalities of LMNA gene expression were reported in either healthy aged cells or cells from patients 
with lamin A-associated aging syndromes. Considering the mechanosensitive roles that lamin A plays in 
vascular cells, it is important to investigate whether lamin A can mediate these stress-induced responses, 
which could be an underlying mechanism that contributes to the initiation of cardiovascular diseases.  
Besides the advances in research that were discussed above, there are several remaining 
concerns to be addressed to fully understand the relationship between A-type lamins and atherosclerosis 
development during aging. For example, what are the functional differences between lamin A and lamin 
C in the mammalian cell aging process, and are they complementary to each other? How do senescent 
cells communicate with its surrounding non-senescent cells to achieve tissue-level changes? Ongoing 
research on these topics will help to explain the occurrence of laminopathies with accelerated aging 
syndrome, as well as the onset of vascular diseases with aging as the risk factor. 
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